(1)
Kaustubh Bhardwaj; Himanshi Bhardwaj; Amit Tripathi; Latika Tolia; Snigdh Agarwal; Devashish Srivastava; Swaraj Verma. FUTURE CHALLENGES AND EMERGING SAFETY CONCERNS OF GLP-1 RECEPTOR AGONISTS, DUAL INCRETIN AGONISTS, AND SGLT2 INHIBITORS. J Popl Ther Clin Pharmacol 2026, 33 (2), 963-981. https://doi.org/10.69980/mng8r305.